Hongbo Medicine: It is expected that the net profit attributable to the parent company will increase by 82.64% to 123.03% in 2025.

Hongbo Pharmaceutical announced on January 27th that it is expected to achieve a net profit attributable to the parent company of 31.2 million to 38.1 million yuan by 2025, an increase of 82.64% to 123.03% compared to the previous year.